Drug Trial Radar · NCT02814409
Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis
Last checked: Nov 20, 2026Latest source record: Jun 13, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,858
Actual
Start
Dec 15, 2016
Primary completion
Aug 31, 2023
Study completion Jan 10, 2024
Sponsor
- Lead sponsor
- NHS Greater Glasgow and ClydeAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of Glasgow; University of Edinburgh; Oxford University Hospitals NHS Trust
- First posted
- Jun 27, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The principle research question is: in patients with acute ischaemic stroke eligible for intravenous (IV) thrombolysis, is tenecteplase superior in efficacy to alteplase, based on functional outcome as assessed by modified Rankin Scale distribution at day 90?
Conditions
- Ischemic Stroke
Interventions
Intravenous recombinant tissue plasminogen activator (rtPA) AlteplaseDrug
IV Alteplase 0.9mg/kg (max 90mg) bolus + 1h infusion
Intravenous TenecteplaseDrug
IV Tenecteplase 0.25mg/kg (max 25mg) single bolus
Primary outcomes
What the sponsor says the trial is designed to measure.
- modified Rankin ScaleTime frame: Day 90 (+/- 7)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Queen Elizabeth University Hospital
Glasgow, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.